Form 4: Exelixis EVP & General Counsel Jeffrey Hessekiel Reports Stock Transactions
SEC Form 4 Filing
Jeffrey Hessekiel, EVP & General Counsel of Exelixis, reports the disposition and acquisition of company stock, including shares withheld for tax obligations and sales on the open market.
Summary
- On May 15, 2025, Jeffrey Hessekiel, EVP & General Counsel of Exelixis, disposed of 34,035 shares of common stock to cover tax obligations related to vesting restricted stock units at a price of $44.65 per share.
- He also sold 25,000 shares on the same day at a weighted average price of $46.18, with individual sales ranging from $46.04 to $46.48.
- Following these transactions, Hessekiel directly owns 693,396 shares and indirectly owns 999 shares through the Exelixis, Inc. 401(k) Plan.
- The direct holdings include shares to be issued upon vesting of RSUs and PSUs, as well as shares acquired through the Employee Stock Purchase Plan.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment. It's a factual report of insider trading activity.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is a common occurrence in publicly traded companies. It provides transparency to investors regarding insider activity.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies, ensuring transparency regarding insider transactions.
- Similar filings are made by executives at comparable companies like Amgen, Gilead Sciences, and Biogen, detailing their stock acquisitions and disposals.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a company executive.
- The filing provides transparency to stakeholders regarding insider activity, which can influence investor confidence.
Key Dates
| Date | Description |
|---|---|
| 03/04/2021 | Date of restricted stock units (RSUs) awarded. |
| 03/04/2022 | Date of restricted stock units (RSUs) awarded. |
| 04/03/2023 | Date of restricted stock units (RSUs) awarded. |
| 02/23/2024 | Date of restricted stock units (RSUs) awarded. |
| 05/14/2025 | Date of Exelixis, Inc. 401(k) Plan statement. |
| 05/15/2025 | Date of stock transactions (disposal and sale). |
| 04/30/2025 | Date of Common Stock acquired on pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. |
| 05/16/2025 | Date of signature on the Form 4 filing. |
Keywords
Exelixis, Hessekiel, Stock Transactions, Form 4, Beneficial Ownership, RSUs, PSUs, Employee Stock Purchase Plan, 401(k)
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.